Persistent low energy and chronic fatigue are among the most common complaints in adult medicine — and among the most inadequately evaluated. At Advanced Vitality Group, persistent, unexplained fatigue is evaluated through a comprehensive biomarker assessment designed to identify specific, correctable biological contributors.
Energy Optimization: Medical Evaluation and Treatment of Clinically Relevant Causes of Low Energy
Persistent low energy and chronic fatigue are among the most common complaints in adult medicine — and among the most inadequately evaluated. At Advanced Vitality Group, persistent, unexplained fatigue is evaluated through a comprehensive biomarker assessment designed to identify specific, correctable biological contributors.
This content is for educational purposes only. It does not replace an in-person or telehealth consultation with a licensed clinician, and does not constitute medical advice or a treatment plan. All treatment decisions — including the use of hormones, peptides, supplements, or other agents — require individual clinical evaluation, laboratory confirmation, and licensed physician oversight. Do not self-administer any medication or compound based on information in this article.
Persistent low energy and chronic fatigue are among the most common complaints in adult medicine — and among the most inadequately evaluated. When standard blood work returns within population reference ranges and no acute illness is found, patients are frequently told their fatigue has no identifiable cause. At Advanced Vitality Group, we approach this differently: persistent, unexplained fatigue is evaluated through a comprehensive biomarker assessment designed to identify specific, correctable biological contributors.
This is not a program to “optimize energy” in already-healthy individuals through hormones or supplements. It is a medical evaluation for patients with symptoms that may reflect documented deficiencies or dysfunction in hormonal, thyroid, mitochondrial, or nutritional systems.
Who This Evaluation Is For
Medical evaluation for energy and fatigue may be appropriate for adults with:
- Persistent fatigue that is disproportionate to activity level and does not resolve with adequate sleep
- Reduced exercise tolerance or significantly slower recovery from physical activity than expected
- Symptoms potentially consistent with thyroid dysfunction: cold intolerance, weight changes, cognitive slowing, dry skin, hair changes
- Symptoms potentially consistent with testosterone deficiency in men: reduced libido, mood changes, loss of morning erections, reduced muscle mass alongside persistent fatigue
- Suspected nutritional deficiencies (iron, vitamin D, B12, magnesium) not previously evaluated
- Symptoms of poor metabolic health: energy instability, difficulty losing fat, poor body composition response to appropriate diet and exercise
The Most Common Medically Correctable Causes of Persistent Fatigue
Thyroid Dysfunction — Hypothyroidism Symptoms
The thyroid gland regulates the metabolic rate of every cell through T3 (triiodothyronine) and T4 (thyroxine). Hypothyroidism symptoms — fatigue, cold intolerance, cognitive slowing, weight gain, reduced exercise capacity — can be present even when TSH falls within standard laboratory reference ranges. Free T3, the metabolically active thyroid hormone, is evaluated when clinically indicated. Subclinical hypothyroidism — elevated TSH with normal Free T4 — affects approximately 5–10% of adults and is associated with fatigue and metabolic dysfunction in some patients.
Thyroid evaluation at Advanced Vitality Group includes TSH and free hormone assessment when clinically indicated. Treatment decisions follow American Thyroid Association guidelines and are individualized based on symptom burden, TSH level, age, and comorbidities — not applied uniformly.
Testosterone Deficiency (Men)
In men, fatigue and reduced vitality are among the most consistent symptoms of testosterone deficiency. The Testosterone Trials (Snyder PJ et al., NEJM, 2016) demonstrated that men with confirmed low testosterone who received TRT reported significantly improved vitality compared to placebo. Assessment requires both symptomatic evaluation and laboratory confirmation of consistently low testosterone, per Endocrine Society and AUA clinical practice guidelines. Low-normal testosterone in the absence of consistent symptoms is not itself an indication for treatment.
Iron Deficiency
Iron deficiency without anemia — low ferritin with normal hemoglobin — is a frequently missed cause of fatigue and exercise intolerance. Iron is required for cytochrome c in the mitochondrial electron transport chain, and iron-deficient mitochondria produce less ATP regardless of oxygen availability. Performance-context ferritin thresholds may be clinically higher than standard deficiency cutoffs, though the appropriate target varies by individual clinical context. A randomized controlled trial (Hinton PS et al., Journal of Nutrition, 2000) demonstrated measurable improvements in endurance performance with iron supplementation in iron-depleted non-anemic women.
Mitochondrial Health and NAD+ Decline
Mitochondria generate more than 90% of cellular ATP. NAD+, an essential cofactor for the electron transport chain and sirtuin pathway, declines with age. Clinical data supports the safety and efficacy of NAD+ precursors (NMN, NR) in raising cellular NAD+ levels — Phase 1/2 trials demonstrate measurable increases in muscle NAD+ and mitochondrial gene expression markers (Yoshino M et al., Science, 2021; Elhassan YS et al., Cell Reports Medicine, 2019). Urolithin A (Mitopure) has demonstrated activation of mitophagy and improvements in muscle endurance in an RCT (Andreux PA et al., Nature Metabolism, 2019).
These interventions are used at Advanced Vitality Group where biomarker or clinical evidence supports a mitochondrial component to fatigue — not as general energy supplements. Large Phase 3 RCTs for NAD+ precursors are ongoing; their current evidence base is Phase 1/2.
Vitamin D Deficiency
Vitamin D receptors are expressed in skeletal muscle and regulate genes involved in muscle function and mitochondrial activity. Deficiency is associated with muscle weakness and fatigue. Supplementation to correct confirmed deficiency (25-OH D < 20 ng/mL) or insufficiency (20–29 ng/mL) is well-supported. Individual targets should be determined in clinical context — values in the 40–60 ng/mL range are sometimes discussed as performance-relevant, but these are not universal treatment targets and require individualized interpretation.
Energy Optimization Biomarker Panel
| Biomarker | What Abnormal Values May Suggest | Clinical Notes |
|---|---|---|
| TSH, Free T3, Free T4 | Thyroid dysfunction contributing to fatigue and reduced metabolism | Free hormones assessed when clinically indicated. Treatment per ATA guidelines. |
| Total testosterone (men) | Hypogonadism contributing to fatigue, reduced vitality, and body composition changes | Treatment only with confirmed deficiency + consistent symptoms per ES/AUA guidelines. |
| Ferritin / CBC | Iron deficiency (with or without anemia) impacting energy and exercise capacity | Performance-relevant thresholds may differ from standard deficiency cutoffs; clinical context determines treatment. |
| Vitamin D (25-OH) | Deficiency contributing to muscle weakness, fatigue, and impaired mitochondrial function | Supplement to correct confirmed deficiency. Individual targets in clinical context. |
| Fasting insulin / HOMA-IR | Insulin resistance affecting metabolic flexibility and energy regulation | Lifestyle interventions first-line; pharmacological options in selected patients. |
| Cortisol (morning) | HPA axis dysfunction; patterns of adrenal stress response | Contextual marker. Recovery, sleep, and lifestyle factors take priority in clinical management. |
| Magnesium (RBC) | Deficiency impairing ATP synthesis, neuromuscular function, sleep quality | RBC magnesium more sensitive than serum. Supplement where deficiency confirmed. |
| NAD+ (whole blood) | Mitochondrial energy production capacity; age-related NAD+ decline | Track from baseline; clinical use of NAD+ precursors where supported by evidence. |
These targets should be interpreted in clinical context. They are not universal performance optimization standards applicable to every patient regardless of symptoms or clinical picture.
What This Evaluation Is Not
- Not a program to “boost energy” in already-healthy individuals through hormonal supplementation
- Not a substitute for adequate sleep, stress management, regular exercise, and nutritional adequacy — which have the strongest evidence base for energy and fatigue
- Not blanket prescribing of hormones based on suboptimal lab values without clinical indication
- Not unsupervised use of peptides or hormones
Frequently Asked Questions
Scientific References
- Snyder PJ, et al. “Effects of testosterone treatment in older men.” NEJM. 2016;374(7):611–624.
- Andreux PA, et al. “The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans.” Nature Metabolism. 2019;1(6):595–603.
- Yoshino M, et al. “Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.” Science. 2021.
- Hinton PS, et al. “Iron supplementation improves endurance in iron-depleted, nonanemic women.” Journal of Nutrition. 2000.
- Garber JR, et al. “Clinical Practice Guidelines for Hypothyroidism in Adults.” Thyroid. 2012.
- Endocrine Society. “Testosterone Therapy in Men with Hypogonadism.” JCEM. 2018.
- Nowak A, et al. “Effect of vitamin D3 on self-perceived fatigue.” Medicine. 2016;95(52):e5353.
Start Your Energy Evaluation
Schedule a consultation to identify correctable causes of fatigue through a comprehensive biomarker assessment.